Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Boulamery

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Therapie|April 7, 2011
[Level of evidence for therapeutic drug monitoring of aminoglycosides]Nicolas Venisse, Audrey Boulamery,
Therapie|July 10, 2016
[Not Available]Nicolas Venisse, Audrey Boulamery,
Frontiers in Immunology|December 5, 2017
Regulation of Neuroinflammation: What Role for the Tumor Necrosis Factor-Like Weak Inducer of Apoptosis/Fn14 Pathway?Audrey Boulamery, Sophie Desplat-Jégo
Fundamental & Clinical Pharmacology|June 30, 2015
Nicotine and metabolites determination in human plasma by ultra performance liquid chromatography-tandem mass spectrometry: a simple approach for solving contamination problem and clinical applicationNatalia Liachenko, Audrey Boulamery, Nicolas Simon
Therapie|September 14, 2004
[Involvement of a public pharmacology laboratory in pharmacokinetic studies]Nicolas Simon, Audrey Boulamery, Bernard Bruguerolle
Journal of Pharmaceutical Sciences|August 21, 2007
Biological rhythms: a neglected factor of variability in pharmacokinetic studiesBernard Bruguerolle, Audrey Boulamery, Nicolas Simon
Therapie|April 7, 2011
[Level of evidence for therapeutic drug monitoring of teicoplatin]Audrey Boulamery, Nicolas Venisse, Chantal Le Guellec, et al.
Fundamental & Clinical Pharmacology|May 8, 2013
Population pharmacokinetics of ertapenem in juvenile and old ratsAudrey Boulamery, Amélie Marsot, Bernard Bruguerolle, et al.
Therapie|July 10, 2016
[Not Available]Audrey Boulamery, Nicolas Venisse, Chantal Le Guellec, et al.
Clinical Pharmacokinetics|November 27, 2012
Population pharmacokinetic analysis during the first 2 years of life: an overviewAmélie Marsot, Audrey Boulamery, Bernard Bruguerolle, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Therapie|April 7, 2011
[Level of evidence for therapeutic drug monitoring of aminoglycosides]Nicolas Venisse, Audrey Boulamery,
Therapie|July 10, 2016
[Not Available]Nicolas Venisse, Audrey Boulamery,
Frontiers in Immunology|December 5, 2017
Regulation of Neuroinflammation: What Role for the Tumor Necrosis Factor-Like Weak Inducer of Apoptosis/Fn14 Pathway?Audrey Boulamery, Sophie Desplat-Jégo
Fundamental & Clinical Pharmacology|June 30, 2015
Nicotine and metabolites determination in human plasma by ultra performance liquid chromatography-tandem mass spectrometry: a simple approach for solving contamination problem and clinical applicationNatalia Liachenko, Audrey Boulamery, Nicolas Simon
Therapie|September 14, 2004
[Involvement of a public pharmacology laboratory in pharmacokinetic studies]Nicolas Simon, Audrey Boulamery, Bernard Bruguerolle
Journal of Pharmaceutical Sciences|August 21, 2007
Biological rhythms: a neglected factor of variability in pharmacokinetic studiesBernard Bruguerolle, Audrey Boulamery, Nicolas Simon
Therapie|April 7, 2011
[Level of evidence for therapeutic drug monitoring of teicoplatin]Audrey Boulamery, Nicolas Venisse, Chantal Le Guellec, et al.
Fundamental & Clinical Pharmacology|May 8, 2013
Population pharmacokinetics of ertapenem in juvenile and old ratsAudrey Boulamery, Amélie Marsot, Bernard Bruguerolle, et al.
Therapie|July 10, 2016
[Not Available]Audrey Boulamery, Nicolas Venisse, Chantal Le Guellec, et al.
Clinical Pharmacokinetics|November 27, 2012
Population pharmacokinetic analysis during the first 2 years of life: an overviewAmélie Marsot, Audrey Boulamery, Bernard Bruguerolle, et al.
Pageof 3